Clinical–Radiological Severity Mismatch Phenomenon: Patients with Severe Neurological Deficits Without Matching Infarction on Computed Tomographic Scan

The objective was to determine the long‐term outcome of patients with severe persistent neurological deficits without a large infarction on computed tomographic (CT) scan.

[1]  S. Shimizu,et al.  Clinical features and functional outcome of stroke after transient ischemic attack. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  Ivana Galinovic,et al.  DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study , 2011, The Lancet Neurology.

[3]  M. Kaste,et al.  Outcome by Stroke Etiology in Patients Receiving Thrombolytic Treatment: Descriptive Subtype Analysis , 2011, Stroke.

[4]  P. Sundgren,et al.  Combined clinical and radiological prognostic model in acute ischemic stroke. , 2010, Acta neurologica Belgica.

[5]  D. Liebeskind,et al.  Stunned brain syndrome: serial diffusion perfusion MRI of delayed recovery following revascularisation for acute ischaemic stroke , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  Pamela W Schaefer,et al.  Combining Acute Diffusion-Weighted Imaging and Mean Transmit Time Lesion Volumes With National Institutes of Health Stroke Scale Score Improves the Prediction of Acute Stroke Outcome , 2010, Stroke.

[7]  David C. Reutens,et al.  Development of a new tool to correlate stroke outcome with infarct topography: A proof-of-concept study , 2010, NeuroImage.

[8]  P. Barber,et al.  Clinical–Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke , 2009, Stroke.

[9]  R. Brouns,et al.  Clinical, Biochemical and Neuroimaging Parameters after Thrombolytic Therapy Predict Long-Term Stroke Outcome , 2009, European Neurology.

[10]  J. Serena,et al.  The Prognostic Value of Capillary Glucose Levels in Acute Stroke: The GLycemia in Acute Stroke (GLIAS) Study , 2009, Stroke.

[11]  D. Pelz,et al.  Acute Stroke with Hyperdense Middle Cerebral Artery Sign Benefits from IV rtPA , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[12]  H. Tei,et al.  Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction , 2007, Journal of Neurology.

[13]  G. Kwakkel,et al.  Predictive Value of Ischemic Lesion Volume Assessed With Magnetic Resonance Imaging for Neurological Deficits and Functional Outcome Poststroke: A Critical Review of the Literature , 2006, Neurorehabilitation and neural repair.

[14]  Carlos A Molina,et al.  Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis: Risk Stratification in Relation to Time to Reperfusion , 2004, Stroke.

[15]  A. Alexandrov,et al.  Ischemic Stunning of the Brain: Early Recanalization Without Immediate Clinical Improvement in Acute Ischemic Stroke , 2004, Stroke.

[16]  D. Tong,et al.  Efficacy of IV tissue plasminogen activator in acute stroke , 2003, Neurology.

[17]  J. Broderick,et al.  Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial , 2002, Neurology.

[18]  D. Wagner,et al.  Combined Clinical and Imaging Information as an Early Stroke Outcome Measure , 2002, Stroke.

[19]  J. Grotta,et al.  Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. , 2001, JAMA.

[20]  A. Algra,et al.  Reproducibility of Measurements of Cerebral Infarct Volume on CT Scans , 2001, Stroke.

[21]  Ninds,et al.  Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography , 2000, Stroke.

[22]  L. Rumbach,et al.  Role of a Stroke Data Bank in Evaluating Cerebral Infarction Subtypes: Patterns and Outcome of 1,776 Consecutive Patients from the Besançon Stroke Registry , 2000, Cerebrovascular Diseases.

[23]  J. Bogousslavsky,et al.  Do transient ischemic attacks have a neuroprotective effect? , 2000, Neurology.

[24]  Y. Okita,et al.  MRA of the Adamkiewicz artery: a preoperative study for thoracic aortic aneurysm. , 2000, Journal of computer assisted tomography.

[25]  G. Albers,et al.  Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. , 2000, JAMA.

[26]  S. Hajat,et al.  Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients. , 2000, Stroke.

[27]  J F Potter,et al.  Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? , 2000, Stroke.

[28]  W R Clarke,et al.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.

[29]  L Bozzao,et al.  Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. , 1999, Stroke.

[30]  H. Adams,et al.  Acute blood glucose level and outcome from ischemic stroke , 1999, Neurology.

[31]  J. Marrugat,et al.  Timing for fever-related brain damage in acute ischemic stroke. , 1998, Stroke.

[32]  L. Wilkins.  Large infarcts in the middle cerebral artery territory , 1998, Neurology.

[33]  J. Bogousslavsky,et al.  Large infarcts in the middle cerebral artery territory Etiology and outcome patterns , 1998, Neurology.

[34]  P. Pullicino,et al.  Interrater Agreement of Computed Tomography Infarct Measurement , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[35]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[36]  P D Lyden,et al.  A Rapid, Reliable, and Valid Method for Measuring Infarct and Brain Compartment Volumes From Computed Tomographic Scans , 1994, Stroke.

[37]  N. Taub,et al.  Assessment of Scales of Disability and Handicap for Stroke Patients , 1991, Stroke.

[38]  L. Shuer,et al.  Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. , 1990, Stroke.

[39]  J. Rankin.  Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis , 1957, Scottish medical journal.

[40]  V. Anderson,et al.  Outcome Measure , 2011 .

[41]  A. Rabinstein.  Clinical-Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke , 2010 .

[42]  S. Levine.  Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography , 2000 .

[43]  R. Anderson,et al.  Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. , 1999, Stroke.

[44]  J. Broderick,et al.  Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. , 1996, AJNR. American journal of neuroradiology.

[45]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.